NEW MOLECULAR INSIGHTS IN EMERGING THERAPEUTIC STRATEGIES IN ACUTE LYMPHOBLASTIC LEUKEMIA
DATES: February 28 - March 2, 2014
LOCATION: Lisbon – Portugal
CHAIR: Dieter Hoelzer
CO-CHAIRS: Nicola Gökbuget, Renato Bassan, Adele Fielding, Robin Foà, Hervé Dombret, Josep Ribera
The EHA Scientific Working Group for Adult ALL (EWALL) and EHA organized a three-day meeting focused on recent advances in emerging therapeutic strategies in acute lymphoblastic leukemia.
This meeting covered the individualized treatment strategies in ALL, combination of different treatment modalities; chemotherapy, antibody therapy, targeted inhibitors, stem cell transplantation and new approaches in non-chemo therapy in elderly. In particular, this meeting provided an innovative format that included e.g. Round table discussions. Besides that voting boxes will be used for the self-assessment of participants.
The meeting was targeted towards specialists in hematology, clinicians involved in ALL, basic researchers, biologists, students and everybody interested in this specific section of hematology.
Participants of this meeting were eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EHA-CME system.
A report of this meeting has been published and is now available here.
Friday, February 28
Saturday, March 1
Sunday, March 2